{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T13:29:11Z","timestamp":1773408551177,"version":"3.50.1"},"reference-count":19,"publisher":"BMJ","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Reports"],"accepted":{"date-parts":[[2014,2,10]]},"abstract":"<jats:p>A 52-year-old woman with overlap syndrome and interstitial pneumonia underwent immunosuppressive therapy and she was suspected to suffer from pulmonary aspergillosis. Oral voriconazole was initiated, and a rapid elevation of alkaline phosphatase (ALP) occurred after 4\u2005weeks. After 2\u2005months, the patient presented diffuse pain in bilateral skeletal regions, and bone scintigraphy revealed bilateral multiple areas of increased radiotracer uptake. We suspected the skeletal involvement as voriconazole-induced periostitis. Actually, the plasma fluoride level was increased. Voriconazole was replaced with itraconazole, and after 3\u2005weeks, the patient stopped complaining of bone pain concomitant with the decrease in ALP. Voriconazole-induced periostitis is a rare condition but had previously been reported in solid organ or patients with bone marrow transplant who received a long-term voriconazole therapy. Our present case is distinctive of previous ones, because it occurred in a patient with connective tissue disease which had its rapid progression.<\/jats:p>","DOI":"10.1136\/bcr-2013-203485","type":"journal-article","created":{"date-parts":[[2014,3,5]],"date-time":"2014-03-05T11:45:00Z","timestamp":1394019900000},"page":"bcr2013203485","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":13,"title":["Voriconazole-induced periostitis in a patient with overlap syndromes"],"prefix":"10.1136","volume":"2014","author":[{"given":"Keisho","family":"Hirota","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiro","family":"Yasoda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshihito","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuya","family":"Inagaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2014,3,5]]},"reference":[{"key":"2025042702474731000_2014.mar05_1.bcr2013203485.1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.pharmtox.41.1.443"},{"key":"2025042702474731000_2014.mar05_1.bcr2013203485.2","doi-asserted-by":"publisher","DOI":"10.1086\/525258"},{"key":"2025042702474731000_2014.mar05_1.bcr2013203485.3","doi-asserted-by":"publisher","DOI":"10.1111\/1469-0691.12039"},{"key":"2025042702474731000_2014.mar05_1.bcr2013203485.4","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2012.03915.x"},{"key":"2025042702474731000_2014.mar05_1.bcr2013203485.5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2009.02837.x"},{"key":"2025042702474731000_2014.mar05_1.bcr2013203485.6","doi-asserted-by":"publisher","DOI":"10.1097\/RLU.0b013e31820902d8"},{"key":"2025042702474731000_2014.mar05_1.bcr2013203485.7","doi-asserted-by":"publisher","DOI":"10.1007\/s00256-010-0997-y"},{"key":"2025042702474731000_2014.mar05_1.bcr2013203485.8","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciq188"},{"key":"2025042702474731000_2014.mar05_1.bcr2013203485.9","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.35.9604"},{"key":"2025042702474731000_2014.mar05_1.bcr2013203485.10","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-011-1922-x"},{"key":"2025042702474731000_2014.mar05_1.bcr2013203485.11","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-01-403030"},{"key":"2025042702474731000_2014.mar05_1.bcr2013203485.12","doi-asserted-by":"publisher","DOI":"10.1002\/art.34618"},{"key":"2025042702474731000_2014.mar05_1.bcr2013203485.13","doi-asserted-by":"publisher","DOI":"10.1097\/RHU.0000000000000045"},{"key":"2025042702474731000_2014.mar05_1.bcr2013203485.14","doi-asserted-by":"crossref","unstructured":"Wergedal JE Lau KH Baylink DJ . Fluoride and bovine bone extract influence cell proliferation and phosphatase activities in human bone cell cultures. Clin Orthop Relat Res 1988:274\u201382.","DOI":"10.1097\/00003086-198808000-00034"},{"key":"2025042702474731000_2014.mar05_1.bcr2013203485.15","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1002\/jbmr.5650101012","article-title":"Pretreatment with low doses of norethindrone potentiates the osteogenic effects of fluoride on human osteosarcoma cells","volume":"10","author":"Takada","year":"1995","journal-title":"J Bone Miner Res"},{"key":"2025042702474731000_2014.mar05_1.bcr2013203485.16","first-page":"279","article-title":"Skeletal fluorosis in humans: a review of recent progress in the understanding of the disease","volume":"10","author":"Krishnamachari","year":"1986","journal-title":"Prog Food Nutr Sci"},{"key":"2025042702474731000_2014.mar05_1.bcr2013203485.17","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199003223221203"},{"key":"2025042702474731000_2014.mar05_1.bcr2013203485.18","unstructured":"Environmental Health Criteria 227: FLUORIDE. Geneva: World Health Organization, 2002."},{"key":"2025042702474731000_2014.mar05_1.bcr2013203485.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2009.11.014"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2013-203485","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,27]],"date-time":"2025-04-27T09:47:53Z","timestamp":1745747273000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2013-203485"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,5]]},"references-count":19,"alternative-id":["10.1136\/bcr-2013-203485"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2013-203485","relation":{},"ISSN":["1757-790X"],"issn-type":[{"value":"1757-790X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,5]]}}}